January 20, 2026 - 21:16

Phase-EQ's innovative grid-enhancing technology has made significant strides in 2025, resulting in a remarkable 60% increase in deployments across the United States. This cutting-edge technology has the potential to unlock up to 25% more capacity in electrical grids, providing a vital solution to the growing energy demands faced by utility companies.
As the need for efficient energy management becomes increasingly critical, Phase-EQ's technology is now operational in over 10 utility areas nationwide. This expansion not only demonstrates the effectiveness of the technology but also highlights the growing recognition among utility providers of the importance of enhancing grid performance.
The deployment of this technology is expected to facilitate better energy distribution, reduce congestion, and increase the overall reliability of the power supply. As energy consumption continues to rise, advancements like those from Phase-EQ are essential for modernizing the grid and ensuring a sustainable energy future.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...